Sa. Stone et al., Serologic prevalence of antibody to human herpesvirus type 8 in patients with various monoclonal gammopathies, LEUK LYMPH, 37(1-2), 2000, pp. 197-203
Both viral and serologic studies have consistently shown an association of
human herpesvirus type 8 (HHV-8) with Kaposi's sarcoma, primary effusion ly
mphoma, and Castleman's disease. The presence of HHV-8 DNA in patients with
myeloma has been reported by some investigators but not substantiated by o
thers, In addition, variable results have been obtained with serologic stud
ies for HHV-8 in patients with myeloma and certain other monoclonal gammopa
thies (MG), We tested 238 coded serum or plasma samples from 96 patients wi
th various MG for antibodies to lytic and latent HHV-8 antigens by indirect
immunofluorescence. Thirty-four of 96 (35%) patients were positive-for the
lytic antibody, but none were positive for the latent antibody. Patients w
ith kappa or lambda light chain myeloma were often positive for the lytic a
ntibody when compared to patients with IgG or IgA myeloma (8 of 11 [73%] vs
. 12 of 38 [32%], P = 0.033). The patients with light chain myeloma also we
re more likely to be positive when compared to patients with Waldenstrom's
macroglobulinemia (WM) (4 of 15 [27%], P = 0.045) or AL amyloidosis (4 of 1
3 [31%], P = 0.047), Four of 9 (44%) patients with monoclonal gammopathy of
undetermined significance (MGUS) were positive. However, 4 other patients
who progressed from MGUS to myeloma were negative. Subgroup analysis of MG
may help clarify the role of HHV-8 in these disorders.